Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis.

Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. J Allergy Clin Immunol. 2012 Nov; 130(5):1216-8.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.